Sequential treatment for advanced head-and-neck cancer
Author Information
Author(s): Bhide S A, Ahmed M, Barbachano Y, Newbold K, Harrington K J, Nutting C M
Primary Institution: Royal Marsden Hospital
Hypothesis
The study investigates the effectiveness of sequential induction chemotherapy followed by radical chemo-radiation in treating locoregionally advanced head-and-neck cancer.
Conclusion
Induction chemotherapy followed by radical chemo-radiation is a safe and tolerable regimen that results in lower distant recurrence rates with equivalent local control and survival compared to chemo-radiation alone.
Supporting Evidence
- Local control rate at 2 years was 71%.
- Disease-specific survival at 2 years was 68%.
- Overall survival at 2 years was 63%.
- Distant recurrence rate at 2 years was 9%.
- 82% of patients completed full-dose concomitant cisplatin.
Takeaway
Doctors used a special treatment plan for patients with advanced throat cancer, and it worked well to keep the cancer from coming back.
Methodology
Patients received two cycles of induction chemotherapy followed by radical chemo-radiation, with data collected on relapse patterns and toxicity.
Potential Biases
Potential selection bias due to the retrospective nature of the study.
Limitations
The study is retrospective and may not account for all variables affecting outcomes.
Participant Demographics
Median age was 58 years, with 76% male and 54% having oropharyngeal cancer.
Statistical Information
Confidence Interval
71% (95% CI: 62 – 79%) for local control at 2 years; 63% (95% CI: 53 – 71%) for overall survival at 2 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website